Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	40.67	74.19	52.74
Graham Fair Price	-11.09	1.93	2.17
PEG	81.69	-1.14	-6.21
Price/Book	7.80	2.19	2.03
Price/Cash Flow	-1172.16	-277.22	-21.79
Prices/Earnings	42.68	25.80	18.08
Price/Sales	22.39	8.30	6.78
Price/FCF	-1172.16	-277.22	-21.79
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-13.09	0.26	0.30
Operating Margin	-28.35	0.11	0.15
ROA	-28.33	< 0.005	0.01
ROE	0.03	0.02	-24.44
ROIC	0.02	0.01	-34.15
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.14	0.06	132.09
Dividends QOQ	0.16	0.24	49.66
EBIT QOQ	0.16	-0.35	125.86
EPS QOQ	-0.03	-0.23	-679.21
FCF QOQ	-1.11	0.91	-17.69
Revenue QOQ	-0.27	-0.10	63.22
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	101.58	120.42	18.55
Days Sales Outstanding (DSO)	40.96	57.15	39.54
Inventory Turnover	0.89	0.75	-15.64
Debt/Capitalization	0.43	0.45	6.08
Quick Ratio	0.33	0.39	20.65
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.73	2.79	2.29
Cash	0.54	0.78	44.83
Capex	-0.19	-0.14	25.01
Free Cash Flow	-0.25	-0.02	91.33
Revenue	0.82	0.74	-9.90
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.64	0.70	9.12
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.69	14.12	32.14
Naive Interpretation	Member

06 - Financial Health · Bad

Rating